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Background: Glucocorticoids (GCs) are commonly used in many chemotherapeutic protocols and play an
important role in the normal regulation of bone remodeling. However, the prolonged use of GCs results
in osteoporosis, which is partially due to apoptosis of osteoblasts and osteocytes. In this study, effects of
Korean Red Ginseng (KRG) on GC-treated murine osteoblastic MC3T3-E1 cells and a GC-induced oste-
oporosis mouse model were investigated.
Methods: MC3T3-E1 cells were exposed to dexamethasone (Dex) with or without KRG and cell viability
was measured by the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. Real-
time polymerase chain reaction was performed to evaluate the apoptotic gene expression; osteogenic
gene expression and alkaline phosphatase (ALP) activity were also measured. Western blotting was
performed to evaluate the mitogen-activated protein kinase (MAPK) proteins. A GC-induced osteoporosis
animal model was used for in vivo study.
Results and conclusion: The MTT assay revealed that Korean Red Ginseng (KRG) prevents loss of cell
viability caused by Dex-induced apoptosis in MC3T3E1 cells. Real-time polymerase chain reaction data
showed that groups treated with both Dex and KRG exhibited lower mRNA levels of caspase-3 and -9,
whereas the mRNA levels of Bcl2, IAPs, and XIAP increased. Moreover, groups treated with both Dex and
KRG demonstrated increased mRNA levels of ALP, RUNX2, and bone morphogenic proteins as well as
increased ALP activity in MC3T3-E1 cells, compared to cells treated with Dex only. In addition, KRG
increased protein kinase B (AKT) phosphorylation and decreased c-Jun N-terminal kinase (JNK) phos-
phorylation. Moreover, microcomputed tomography analysis of the femurs showed that GC implantation
caused trabecular bone loss. However, a signiﬁcant reduction of bone loss was observed in the KRG-
treated group. These results suggest that the molecular mechanism of KRG in the GC-induced apoptosis
may lead to the development of therapeutic strategies to prevent and/or delay osteoporosis.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Glucocorticoids (GCs) are used most extensively as anti-in-
ﬂammatory and immunosuppressive drugs to treat a variety of
diseases such as inﬂammation, cancer, and autoimmune disorders.
However, protracted usage or a large dose of GC may be the main
reason of osteoporosis. GCs have been reported to exhibit detri-
mental effects on the proliferation and function of osteoblasts. For
example, dexamethasone (Dex), a synthetic GC hormone, has beene, Gachon University, 1342 Seongn
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e Korean Society of Ginseng, Publdescribed to inhibit the synthesis of both ﬁbronectin and collagen,
as well as stimulating collagenase synthesis [1,2]. Evidence has
shown that GCs induce apoptosis in both bone and cartilage,
causing excessive or premature loss of osteoblast precursors,
osteocytes, and articular and growth plate chondrocytes [3]. The
mechanism of GC-induced apoptotic cell death is not elucidated.
Weinstein et al [4] demonstrated that prednisone increases the rate
of apoptosis in both osteoblasts and osteocytes in adult mice. Gohel
et al [5] also reported that corticosterone induces apoptosis in ratamdaero, Sujung-gu, Seongnam-si, Gyeonggi-do, Seongnam 461-701, Korea.
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Chua et al [6] showed that Dex-induced apoptosis is involved in the
activation of several types of caspase genes. All these effects lead to
decreased bone formation, ultimately causing bone disease and
osteoporosis [7].
For over 2,000 years, ginseng (Panax ginseng Meyer) has been
regarded as the most important herbal medicine traditionally in
East Asia. Currently, ginseng is one of the extensively used botanical
products in the world [8]. It is associated with intrinsic attributes
such as antioxidant, anticancer, antidiabetic, and antiadipogenic
activities [9,10]. Few studies have investigated the antiosteoporotic
activity of ginseng [11]. Korean Red Ginseng (KRG) is essentially
Panax ginseng that has been heat processed to enhance its biolog-
ical and pharmacological activities. KRG and its extracts have been
shown to possess multiple pharmacological activities that are
useful for treating various human diseases, such as cardiovascular
diseases, hypertension, wounds, cerebral ischemia, diabetes mel-
litus, liver regeneration, antiangiogenesis, and rheumatoid arthritis
[12e18]. In recent days, the use of whole ginseng products such as
steamed ginseng (KRG), ginseng powder, and ginseng extracts has
seen a resurgence in use as alternative medicines in Europe as well
as in Asian countries. However, the protective activity of KRG
against Dex-induced osteoporosis in vitro and in vivo has not yet
been comprehensively explained.
In this study, we determined the protective effects of KRG
against Dex-induced apoptosis, as well as the molecular mecha-
nism regulated by KRG in MC3T3-E1 cells in vitro and the alteration
of trabecular bone loss in a GC-induced osteoporosis mouse model
in vivo.
2. Materials and methods
2.1. Reagents
All the cell culture media and supplements were Gibco products
(Life Technologies, Waltham, MA, USA). RNAisol and all polymerase
chain reaction (PCR) reagents were obtained from Takara Bio Inc.
(Shiga, Japan). Dex, ascorbic acid, b-glycerophosphate, and 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
were obtained from Sigma-Aldrich (St Louis, MO, USA). Anti-
phospho-p38 mitogen-activated protein kinase (Thr180/Tyr182),
antiphospho-c-Jun N-terminal kinase (p-JNK; Thr183/Tyr185),
antiphospho-AKT (p-AKT; ser 473), and anti-b actin antibodies
were purchased from Cell Signaling Technology (Danvers, MA,
USA). KRG extracts were provided by the Korea Ginseng Corpora-
tion (Daejeon, Korea) from the roots of a 6-year-old red ginseng
(Panax ginsengMeyer) plant harvested in the Republic of Korea. KRG
was prepared by steaming fresh ginseng at 90e100C for 3 h and
then drying at 50e80C. KRG extract was prepared from red
ginseng water extract, which was extracted at 85e90C using three
8-h cycles of circulating hot water. Water content of the pooled
extract was 36% of the total weight. KRG was analyzed by high-
performance liquid chromatography. The major ginsenosides pre-
sent in KRG extract were as follows: Rb1, 7.53mg/g; Rb2, 2.86mg/g;
Rc, 2.86 mg/g; Rd, 0.89 mg/g; Re, 1.90 mg/g; Rf, 1.12 mg/g; Rg1,
1.78 mg/g; Rg2s, 1.12 mg/g; Rg3r, 0.72 mg/g; and Rg3s, 1.37 mg/g;
minor ginsenosides were also present.
2.2. Cell culture conditions
Osteoblastic MC3T3-E1 cells (CRL-2593; ATCC, VA, USA) were
cultured in a growth medium consisting of minimal essential me-
dium (a-MEM) with 10% fetal bovine serum (FBS) and 1% penicillin/
streptomycin. Cells were incubated in a humid incubator at 37C
(95% O2 and 5% CO2) and maintained in a subconﬂuent state unlessotherwise indicated. Cells were subcultured every 72 h using 0.2%
trypsin and 0.02% ethylenediamine tetra-acetic acid. For experi-
ments, cells were cultured for 24 h to obtain monolayers containing
a-MEM with 10% FBS. For osteogenic differentiation, when cells
reached the conﬂuence, they were cultured in a differentiation
medium (a-MEM with 50 mg/mL ascorbic acid and 10mM b-glyc-
erophosphate) in the absence or presence of KRG and/or Dex. The
medium was changed every 3 d.
2.3. Cell viability after Dex and KRG treatments
Cell viability was assessed by the MTT assay. Brieﬂy, MC3T3-E1
cells were incubated in 96-well plates and maintained in the
growth media for 24 h at 37C. At 80% conﬂuence, cells were
treated with different concentrations of KRG and Dex for 48 h.
Then, 10 mL of MTT solution (5 mg/mL) was added to each well, and
the cells were incubated for another 4 h at 37C. After the formation
of formazan crystals, the MTT medium was aspirated and replaced
with 150 mL of dimethyl sulfoxide (DMSO) for dissolving the for-
mazan crystals. Then, the plates were shaken for 5 min. The
absorbance of each well was recorded at 570 nmwith a microplate
spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
Relative cellular growth was determined by calculating the ratio of
the average absorbance in treatment cells to that in control cells.
Cell viability was expressed as the ratio of optical densities.
2.4. Determination of alkaline phosphatase activity
To measure alkaline phosphatase (ALP) activity, cells were
washed with phosphate-buffered saline twice and sonicated in
lysis buffer consisting of 10mM Tris-HCl (pH 7.5), 0.5mM MgCl2,
and 0.1% Triton X-100. After centrifugation at 10,000 g for 20 min
at 4C, ALP activity in the supernatant was indicated in triplicate
with the LabAssay ALP kit (Wako Pure Chemicals Industries, Chuo-
ku, Osaka, Japan). Protein concentration was analyzed with a
bicinchoninic acid protein assay kit (Thermo Pierce, Rockford, IL).
2.5. Isolation of total RNA and quantitative reverse transcription-
PCR
Total RNA was isolated with the RNAisol PLUS reagent (Takara
Bio Inc.), according to the manufacturer’s protocol. The concen-
tration of total RNA was calculated from its absorbance at 260 nm
and 280 nm, each with an ND1000 spectrophotometer (Thermo,
USA). First-strand cDNA was synthesized with 1 mg of total RNA
according to the manufacturer’s protocol (Takara Bio Inc.). SYBR-
Green-based quantitative real-time PCR was performed using SYBR
Primix Ex Taq (Takara Bio Inc.) with the appropriate sense and
antisense primers. The primer sets used in this study are shown in
Table 1. All reactions were carried out in triplicate and data were
analyzed by the 2eDDCT method. Beta-actinwas used as an internal
standard gene.
2.6. Western blot analysis
Treated cells were washed twice with ice-cold phosphate-
buffered saline and then solubilized in 100 mL of lysis buffer [20mM
Tris-HCl (pH 7.5), 150mM NaCl, 1mM ethylenediamine tetra-acetic
acid, 1mM Ethylene glycol tetraacetic acid (EGTA), 1% Triton X-100,
2.5mM sodium pyrophosphate, 1mM b-glycerophosphate, 1mM
Na3VO4, 50mM NaF, and 1 mg/mL leupeptin). After a freezeethaw
cycle and vortexing for 1 h at 4C, the lysate was clariﬁed by
centrifugation at 12,000  g at 4C for 5 min. The extracts were
separated by sodium dodecyl sulfateepolyacrylamide gel electro-
phoresis and then electroblotted onto a nitrocellulose membrane.
Fig. 1. Effects of KRG on the viability of MC3T3-E1 cells. Cells were treated with KRG
for 48 h. Cell viability was determined using the MTT assay. The experiment was run in
triplicate. KRG, Korean Red Ginseng; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphe-
nyltetrazolium bromide.
Table 1
List of primer sequence for real-time
Gene Forward (50e30) Reverse (50e30)
ALP GCTGATCATTCCCACGTTTT CTGGGCCTGGTAGTTGTTGT
OCN AAGCAGGAGGGCAATAAGGT TTTGTAGGCGGTCTTCAAGC
OPN CGATGATGATGACGATGGAG TGGCATCAGGATACTGTTCATC
RunX2 GCCGGGAATGATGAGAACTA GGACCGTCCACTGTCACTTT
BMP-2 GGGACCCGCTGTCTTCTAGT TCAACTCAAATTCGCTGAGGA
BMP-4 CCTGGTAACCGAATGCTGAT AGCCGGTAAAGATCCCTCAT
BMP-6 CAACGCCCTGTCCAATGAC ACTCTTGCGGTTCAAGGAGTG
BMP-7 CGATACCACCATCGGGAGTTC AAGGTCTCGTTGTCAAATCGC
BMP-9 CAGGTGAGAGCCAAGAGGAG CCTTTGTGGGGAACTTGAGA
Bcl2 ACTTCTCTCGTCGCTACCGT CTGTTGACGCTCTCCACACA
Bcl-Xl CGTAGACAAGGAGATGCAGG TCAGGAACCAGCGGTTGAAG
IAP-1 AAGTGTGTATGGACCGAGAG GGACCATTAGTCTTGTTCAG
IAP-2 TGTGTATGGACAGAGAGGTT CAGCTTCTGATGTCCAACAA
XIAP ATACGGAGGATGAGTCAAGT GGTTGAACGTAATGACGGTG
caspase-3 AGCAGCTTTGTGTGTGTGATTCTAA AGTTTCGGCTTTCCAGTCAGAC
caspase-6 AGACAAGCTGGACAACGTGACC CCAGGAGCCATTCACAGTTTCT
caspase-7 GGAGGACTATGGTGATTGGAGC TAAGGCGCTGGTGGATATGG
caspase-9 GGATCCATGCCCAGACCAGTGGACATTGG GGTCTAGATTATGATGTTTTAAAGAAAAG
b-actin TCACCCACACTCTGCCCAT TCCTTAATGTCACGCACCATTT
PCR, polymerase chain reaction
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nonfat dry milk in Tris-buffered saline with 0.1% Tween-20) for 1 h
at room temperature. The membrane was then incubated with
antibodies overnight at 4C. The membrane was washed and
incubated with horseradish peroxidase-conjugated secondary
antibody for 1 h. The blots were ﬁnally detected by enhanced
chemiluminescence (Amersham Biosciences, Pittsburgh, PA, USA).
2.7. GC-induced osteoporosis animal model
Six-wk-old male Imprinting Control Region (ICR) mice were
obtained from Orientbio (Seongnam, Korea). The slow release
pellets (Innovative Research of America, Sarasota, FL, USA) of GC
(2.1 mg/kg/d prednisolone pellet) were subcutaneously implanted
for 5 wks. The GC-implanted mice were divided into four groups:
(1) negative control; (2) GC pellet implantation control; (3) GC
treated with 100 mg/kg/d of KRG; and (4) GC treated with 500 mg/
kg/d of KRG. After 1 wk of GC implantation, mice were orally
administeredwith 100mg/kg/d or 500mg/kg/d KRG or saline. After
4 wks of treatment, the mice were euthanized for bone analysis.
Radiographic images were taken with a SkyScan1173 micro-
computed tomography system (SkyScan, Kontich, Belgium). All
animal experimental procedures were approved by the Experi-
mental Animal Ethics Committee at Gachon University, Seongnam,
Korea.
2.8. Statistical analysis
All experiments were performed in triplicate. Each value was
presented as the mean standard deviation. Signiﬁcant differences
were determined using the Sigmaplot program (version 6.0).
3. Results
3.1. Effects of KRG on MC3T3-E1 cell viability
Optimal KRG concentrations for MC3T3-E1 cell viability were
determined by the MTT assay. MC3T3-E1 cells (1  104 cells/well)
were seeded in a plate and treated with various concentrations of
KRG for 48 h. The MTT assay indicated that KRG did not affect the
cell viability of MC3T3-E1 at concentrations of 1 mg/mL or lower
(Fig. 1).3.2. Inhibitory effects of Dex on the viability of MC3T3-E1 cells
To elucidate whether Dex, an active GC analog, would promote
the apoptosis of MC3T3-E1 cells or not, the absorbance of cells was
measured by MTT assay. MC3T3-E1 cells were seeded in a 24-well
plate for 24 h and then treated with various concentrations of
Dex (0mM, 50mM, 125mM, and 250mM) for 48 h. No signiﬁcant
morphological changes occurred at 50mM Dex that could be
observed under a light microscope. However, cells treated with
125e250mM Dex underwent apoptosis (data not shown). The MTT
assay veriﬁed that Dex inhibited cell growth in a dose-dependent
manner (Fig. 2). The absorbance of Dex at 125mM in the MTT assay
was signiﬁcantly lower than that of the control group, indicating
that the concentration of Dex required to induce half of the MC3T3-
E1 cells to go through apoptosis was approximately 125mM.
3.3. Effects of KRG on the apoptosis of Dex-exposed MC3T3-E1 cells
To determine whether KRG has protective effects on MC3T3-E1
cells against Dex-induced apoptosis or not, cells were exposed to
100mM Dex and KRG for 48 h. Cell viability was estimated by the
MTT assay. A signiﬁcant decrease in the cell viability of MC3T3-E1
treated with 100mM Dex was observed compared to that of Dex-
and KRG-free cells. By contrast, cell viability increased in cells
Fig. 2. Effect of Dex on the viability of MC3T3-E1 cells. Cells were treated with Dex
(0mM, 50mM, 125mM, and 250mM) for 48 h. Treatment with Dex reduced cell viability,
which was determined using the MTT assay. *p < 0.05 versus control. **p < 0.01 versus
control. Dex, dexamethasone; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenylte-
trazolium bromide.
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only Dex (Fig. 3). These results suggest that KRG prevents Dex-
induced apoptosis in MC3T3-E1 cells in a dose-dependent manner.3.4. Effects of KRG on the mRNA expression levels of apoptosis-
related genes in Dex-exposed MC3T3-E1 cells
Apoptosis is a regulated cellular suicide mechanism that was
characterized by nuclear condensation, cell shrinkage, and DNA
fragmentation. The increase in MC3T3-E1 cell viability upon
treatment with both KRG and Dex suggests that KRGmodulates the
expression of cell death-related genes. Caspases, a family of
cysteine proteases, are the central regulators of apoptosis. To
examine the possibility that the expression of these proteins may
be modulated, expression levels of both proapoptotic genes (cas-
pase-3, -6, -7, and -9) and antiapoptotic genes (BCL-2, IAPs, and
XIPA) were conﬁrmed by quantitative real-time PCR. The treatment
of MC3T3-E1 cells with 100mM Dex for 48 h increased the mRNA
levels of caspases, whereas cells exposed to Dex and KRG decreased
the mRNA levels of caspase-3 and caspase-9 (Fig. 4). However, DexFig. 3. Effect of KRG on the viability of Dex-exposed MC3T3-E1 cells. Cells were treated
with KRG at various concentrations and/or cotreated with Dex (100mM) for 48 h. Cell
viability was determined using the MTT assay. The experiment was run in triplicate.
*p < 0.05 versus Dex control without KRG. **p < 0.01 versus Dex control without KRG.
Dex, dexamethasone; KRG, Korean Red Ginseng; MTT, 3-(4, 5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide.failed to repress the expression of antiapoptotic genes (BCL-2, IAPs,
and XIPA). In fact, Dex signiﬁcantly upregulated the expression of
Bcl-XL, IAP-2, and XIAP (Fig. 5). Therefore, Dexmay induce apoptosis
by upregulating proapoptotic gene expression.
3.5. Effects of KRG on MAPK/AKT signaling in Dex-exposed MC3T3-
E1 cells
To survey the molecular mechanism by which KRG exerts its
antiapoptotic effects, activation of the MAPK/AKT signaling
pathway was examined. MC3T3-E1 cells were incubated with
100mM Dex in the presence or absence of KRG (1 mg/mL) for 24 h.
The JNK, p38, and AKT activation states were reviewed by Western
blot analysis. When cells were exposed to 100mM Dex, the JNK
phosphorylation level increased signiﬁcantly compared to that of
the control, whereas it decreased signiﬁcantly when treated with
both Dex and KRG. Given that AKTactivation protects cells from cell
apoptosis and cell death, we also investigated whether KRG could
induce AKT phosphorylation in Dex-exposed MC3T3-E1 cells or
not. When cells were exposed to 100mM Dex, AKT phosphorylation
decreased signiﬁcantly compared to that of the control, whereas it
increased signiﬁcantly when cells were treated with both Dex and
KRG (Fig. 6).
3.6. Effects of KRG and Dex on the expression of osteogenic gene
markers in MC3T3-E1 cells
To determine the effects of KRG on the expression of osteogenic
gene markers and ALP activity, cells were treated with various
concentrations of KRG and Dex in osteogenic differentiation con-
ditions for 5 d and 7 d. Osteoblastic differentiation was assessed by
using quantitative real-time PCR, by measuring the mRNA expres-
sion levels of ALP, bone morphogenic proteins (BMPs), osteopontin
(OPN), RUNX2, and osteocalcin (OCN). DEX-treated cells showed
decreased ALP activity, but in cells treated with Dex and KRG
(30 mg/mL and 60 mg/mL; Fig. 7A) this activity was increased
signiﬁcantly. Based on quantitative real-time PCR, cells treatedwith
100mM Dex exhibited decreased mRNA expression levels of ALP,
OCN, OPN, RUNX2, BMP-2, -6, -7, and -9, whereas these expression
levels increased in cells treated with both Dex and KRG (Fig. 7B).
3.7. Effects of KRG in a GC-induced osteoporosis animal model
To investigate the effects of KRG in a GC-induced osteoporosis
model, mice implanted with prednisolone pellets were given KRG
(100 mg/kg or 500 mg/kg) orally. In 5 wks, bone loss was measured
by microcomputed tomography. Trabecular bone loss in the femur
was observed in the GC control group. However, mice in the oral
KRG-treated group showed a signiﬁcant reduction in bone loss
(Fig. 8).
4. Discussion
In addition to their use in patients undergoing organ trans-
plantation, GCs have been used in the treatment of autoimmune,
pulmonary, and gastrointestinal disorders. A common side effect of
long-term GC therapy is reduced bone density, which is the most
prevalent form of secondary osteoporosis after menopause.
Increased osteoblast apoptosis has been demonstrated in patients
with GC-induced osteoporosis [19]. Mice implanted with GCs also
have a higher number of apoptotic osteoblasts that inhibit bone
formation [20]. In vitro studies have also revealed that GCs can
induce the apoptosis of osteoblasts [21]. These ﬁndings indicate
that increased osteoblast apoptosis is responsible for GC-induced
bone loss or osteoporosis.
Fig. 4. Effect of KRG on mRNA expression level of caspase-3, -6, -7, and -9 in Dex-exposed MC3T3-E1 cells. RNA was extracted from MC3T3-E1 cells treated with various doses of
KRG and cotreated with Dex (100mM) for 48 h. The mRNA levels were analyzed using quantitative real-time PCR, and relative expression levels were calculated by comparison with
the internal b-actin control. All experiments were performed in triplicate and values are presented as mean  SD. *p < 0.5 versus control. **p < 0.01 versus control. ***p < 0.5 versus
Dex control without KRG. ****p < 0.01 versus Dex control without KRG. Dex, dexamethasone; KRG, Korean Red Ginseng; PCR, polymerase chain reaction; SD, standard deviation.
J Ginseng Res 2015;39:46e5350The apoptotic pathway with multiple interacting components is
complicated, and the important steps in this cascade involve cas-
pase enzymes, which are a family of proteins that play a role in the
degradation of cells targeted to undergo apoptosis. Caspase-3 is an
effector caspase that cleaves nucleases as well as cellular substrates,
and caspase-9 is an initiator caspase that is involved in mitochon-
drial damage [6]. Furthermore, several reports demonstrated thatFig. 5. Effect of KRG on mRNA expression level of antiapoptotic genes in Dex-exposed MC3
and cotreated with Dex (100mM) for 48 h. mRNA levels were analyzed using quantitative
internal b-actin control. All experiments were performed in triplicate, and values are presen
Korean Red Ginseng; PCR, polymerase chain reaction; SD, standard deviation.the Extracellular signal-regulated kinase (ERK) activation is
essential for cell survival, whereas the activation of JNK and p38
plays an important role in cell death signaling [22,23]. The phos-
phatidylinositol 3-kinase/AKT pathway is also viewed as a key
factor for cell survival in different cell systems [24]. Notably, the
inhibition of the phosphatidylinositol 3-kinase pathway and sub-
sequent AKT phosphorylation appear to be important mechanismsT3-E1 cells. RNA was extracted from MC3T3-E1 cells treated with various doses of KRG
real-time PCR, and relative expression levels were calculated by comparison with the
ted as mean  SD. *p < 0.5 versus Dex control without KRG. Dex, dexamethasone; KRG,
Fig. 6. Effect of KRG on mitogen-activated protein kinase (MAPK) and protein kinase B
(AKT) signaling. MC3T3-E1 cells were treated with Dex (100mM) in the presence or
absence of KRG (1 mg/mL) for 24 h. After 24-h treatment, Western blot analysis using
p-P38, p-JNK, and p-AKTantibodywas performed; b-actinwas used as a loading control.
Dex, dexamethasone; KRG, Korean Red Ginseng; p-AKT, phospho-AKT; p-P38, phospho-
p38 mitogen-activated protein kinase; p-JNK, phospho-c-Jun N-terminal kinase.
A
B
Fig. 7. Effect of KRG and 100mM Dex on (A) ALP activity and (B) mRNA expression of MC3T
cotreated with Dex (100mM) for (A) 7 d and (B) 5 d. The mRNA levels were analyzed using qu
with the internal b-actin control. *p < 0.05 versus Dex. **p < 0.01 versus Dex. ***p < 0.05
protein; DC, differentiation control; Dex, dexamethasone; KRG, Korean Red Ginseng; OCN,
J. Kim et al / Protective effect of Korean Red Ginseng 51of Dex-induced apoptosis. In the present study, the mRNA levels of
caspase-3, -6, -7, and -9 in cells treated with both Dex and KRG
were observed to decrease compared to those in cells treated with
Dex only. This antiapoptotic effect also appeared to be involved in
p-AKT activation and p-JNK inhibition.
Bone-forming osteoblasts are derived from mesenchymal pre-
cursor cells, and the maturation of preosteoblasts differentiated
from mesenchymal precursor cells plays a role in the rebuilding of
resorbed bone by elaborating a matrix that becomes mineralized.
These preosteoblasts become committed by signals for the activa-
tion of osteogenic genes, which are recognizable near the bone
surface due to their proximity to surface osteoblasts and the his-
tochemical detection of ALP enzyme activity, one of the earliest
markers of the osteoblast phenotype. The active mature osteoblast
on the bone surface is distinguished by its morphological proper-
ties as well as by the temporal expression of several non-
collagenous proteins such as OCN and OPN, which act as markers
for mature osteoblasts [25].
BMPs play a major role in the growth and differentiation of
osteoblastic cells and have been shown to be potent stimulators of
bone formation in various animal models. BMP-2 stimulates the
expression of osteogenic genes, such as OCN and ALP [26].
Furthermore, osteogenic BMPs such as BMP-2 and BMP-7 have
recently been approved for clinical application in spinal fusion,
fracture healing, and dental tissue engineering. Anabolic agents3-E1 cell differentiation. Cells were treated with KRG at various concentrations and/or
antitative real-time PCR, and relative expression levels were calculated by comparison
versus DC. ****p < 0.01 versus DC. ALP, alkaline phosphatase; BMP, bone morphogenic
osteocalcin; OPN, osteopontin; PCR, polymerase chain reaction.
Fig. 8. Effect of KRG on glucocorticoid-induced osteoporosis mice model. Slow release pellets of prednisolone (PDS) (2.1 mg/kg/d) were administrated for 35 d by subcutaneous
implantation. One wk after implantation, the mice were orally administrated with KRG extract (100 mg/kg and 500 mg/kg) or saline. After 4 wks, the mice were euthanized for bone
analysis. The femurs were imaged with a micro-CT machine. CT, computed tomography; KRG, Korean Red Ginseng; PDS.
J Ginseng Res 2015;39:46e5352that stimulate BMP expression or its signaling pathway can be used
to treat osteoblast-related diseases via bone formation or regen-
eration [27,28]. Loss of both BMP-2 and -4 has been shown to result
in severe impairment of osteogenesis [29]. The network of activities
and molecular switches for bone development and osteoblastic
differentiation involves BMP-induced transcription factors such as
RUNX2. RUNX2 is one of the osteogenic master transcription fac-
tors, and its activity is increased by BMP-2 signaling [30,31]. In this
study, we observed that the mRNA levels of ALP, OCN, OPN, RUNX2,
and BMPs (BMP-2, -6, -7, and -9) in cells treated with both Dex and
KRG were slightly higher than those in cells treated with only Dex.
Current research efforts aim to prevent GC-induced osteopo-
rosis and decrease the incidence of fractures. However, few studies
have investigated how to improve the repair of fractures that have
occurred during GC treatment. A parathyroid hormone-related
protein analog has been shown to be effective for impaired bone
healing in rabbits receiving corticosteroid therapy. Receptor acti-
vator of nuclear factor kappa-B ligand (RANKL), BMP-2, and BMP-7
have been shown to inhibit bone loss in GC-treated animals [32]. In
addition, the current study veriﬁed that KRG increased bone for-
mation in GC-induced osteoporosis mice model.
In conclusion, GCs have signiﬁcant pharmacological effects on
bone metabolism, including suppression of bone formation and
bone resorption. We observed that KRG prevented synthetic GC
(Dex)-induced apoptosis of MC3T3-E1 cells by inhibiting the acti-
vation of caspase-3 and -9. Gene expression of the osteogenic gene
markers (ALP, OCN, OPN, Runx2, and BMPs) was enhanced in cells
treated with both Dex and KRG compared to that in cells treated
with Dex only. Furthermore, our data indicate that KRG-treated
cells not only activated p-AKT, but also inhibited p-JNK. KRG also
increased bone formation in GC-induced osteoporosis mice. Thus,
KRG can be used as a beneﬁcial therapeutic for the prevention or
treatment of GC-induced osteoporosis.Conﬂict of interest
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